Casein Kinase 2 β-Subunit Is a Regulator of Bone Morphogenetic Protein 2 Signaling

Authors

Beth Bragdon, University of Delaware
Shayamala Thinakaran, University of Delaware
Oleksandra Moseychuk, University of Delaware
Daniel King, University of Delaware
Kira Young, University of Maine
David W. Litchfield, The University of Western OntarioFollow
Nils O. Petersen, University of Alberta
Anja Nohe, University of Delaware

Document Type

Article

Publication Date

8-4-2010

Journal

Biophysical Journal

Volume

99

Issue

3

First Page

897

Last Page

904

URL with Digital Object Identifier

http://dx.doi.org/10.1016/j.bpj.2010.04.070

Abstract

Bone morphogenetic proteins (BMPs) play a crucial role during embryonic development and regulate processes as diverse as neurogenesis, skeletal formation, and hematopoesis. They signal through a hetero-oligomer complex of BMP receptors. Binding of the ligand to the receptors activates several pathways, including Smad and p38. BMP signaling is controlled in the extracellular space, the plasma membrane, and the intracellular space; however, the mechanism of receptor signaling at the plasma membrane and proteins that regulate this process still need to be identified. The experiments presented here identify the protein kinase casein kinase II (CK2) as a BMP receptor type Ia (BRIa) interacting protein. Fluorescence resonance energy transfer revealed that this interaction occurs at the plasma membrane. BMP2 stimulation of C2C12 cells leads to the release of CK2 from BRIa. Blocking this interaction with specific peptides that inhibit the binding sites for CK2 on BRIa demonstrated a redistribution of BRIa on the plasma membrane. Signaling was initiated once CK2 was released from BRIa, leading to the mineralization of C2C12 cells. These data suggest that CK2 is a negative regulator of BMP signaling and osteoblast differentiation.